RGCC Testing And Therapies

By The Woodlands Institute for Health & Wellness

Onco-D-clare screens for dozens of cancers with a simple blood draw.

• ~95% sensitive and specific

Prime spot testing (very sensitive PCR test for microbes)

Q-REstrain (formerly SOT -Supportive Oligonucleotide Therapy) for microbes

• Typically given every 4 to 6 months. Some people need a couple, and some need multiple due to treating multiple microbes, where applicable.
• Another option is to give half dose initially, then the other half a few weeks later. This is determined on an individual basis if someone requires less aggressive therapy.

RGCC Oncotrace

• This can be a screening tool for cancer
• This test looks for circulating tumor cells, and quantifies # of cancer cells per volume of blood. This is used for baseline prior to treatments, and to monitor progress.
• This is ordered typically every 4 mos, but at least every 6 months.
• When results are in, you’ll be asked to schedule an appointment to discuss them and make adjustments to regimen.

RGCC Onconomics Plus

• Extensive test of cancer cells, testing their genetic and tumor markers
• Tests the sensitivity vs resistance to various chemotherapy agents as well as to numerous natural agents, e.g. vitamins, botanicals/herbs.
• Also tests the cancer’s sensitivity to glucose/insulin (ie: whether a ketogenic diet would be helpful in treating
• Also tests the cancer’s sensitivity to heat (ie whether InfraRed sauna, hyperthermia treatments, and/or radiation would be useful in treating)
• When results are in, you’ll be asked to schedule an appointment to discuss them and make adjustments to regimen.

Q-REstrain (formerly SOT -Supportive Oligonucleotide Therapy) for cancer

• Typically given every 4 to 6 months.
• Another option is to give half dose initially, then the other half a few weeks later. This is determined on an individual basis if someone requires less aggressive therapy.
• Patient must be monitored regularly with head scans and body scans (CT, PET)-at minimum, prior to each SOT treatment

Clavic-Q-RE (formerly Vaxo-Q-Re) for cancer

• Vaxo-Q-Re is an advanced therapy consisting of five types of immune cells; macrophages, NK cells, dendritic cells, cytotoxic T lymphocytes and antibody producing plasma cells. Vaxo-Q-re can be effective at treating all forms of cancer. This adoptive T cell-based therapy encourages the body’s immune system to target cancer cells.
• Includes pre-treatment Immune Frame test that is required, and also includes this test, along with Oncotrace, done after treatment at 3 months, and 6 months. It also includes administration of Vaxo-Q-Re which is given by IV, for a total of 3 infusions, each given 2 weeks apart.
• Does not include a pre-treatment Oncotrace that’s also required
• While VAXO-Q-Re can provide long lasting immunity, it’s also possible that the effect can wane if a cancer cell line mutates, so repeating VAXO-Q-Re may be required at some point

Dendritic Cell Therapy

• Dendritic cells (DCs) are known as antigen presenting cells. They are special key regulators of the immune system capable of activating T cells, and stimulating the growth and differentiation of B cells. Dendritic cells identify peptides on the surface of cancer cells and present these to other immune cells so that they can seek and destroy all cancer cells with that specific peptide marker.
• DCs can also stimulate memory cells to provide long lasting immunity; however, it’s possible that the effect may wane and the patient will require another round.
• These are not used for blood cancer, testicular cancer, or brain cancers.
• Includes pre-treatment Immune Frame test that is required, and also includes this test, along with Oncotrace, done 3 weeks after treatment is completed. It also includes administration of DCs which is given by IV, for a total of 3 infusions, each given 3 to 4 weeks apart.
• Does not include a pre-treatment Oncotrace that’s also required

Vaccine prep for cancer

• Vaccine created specifically for the patient’s cancer
• Used for solid tumors only (i.e., not available for leukemia)
• Includes a required Immune Frame test prior to ordering or receiving the vaccine prep. It also includes a post-treatment Immune Frame. This test is for assessing your immune function.
• RGCC also requires Oncotrace or Oncotrail or a “CTC” count prior to ordering vaccine prep. If you have one of these results within 6 months, those will be accepted. Otherwise, additional testing will be required. RGCC will cover the cost of the repeat Oncotrace/Oncotrail which is done 3 weeks after completion of the series.
• Vaccine infused by IV or given in subcutaneous injections
• 9 week protocol—once a wk x 3 wks, then 3 wks off, then weekly again for 3 wks.
• Can be repeated 3 mos after the last infusion, if needed

**Please note that RGCC requires that labs be no more than 6 months old for ordering any applicable therapies